SCHEMBL2994570

SCHEMBL2994570

COc1ccc([N+](=O)[O-])cc1NS(=O)(=O)c1ccc(Br)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.79
LMNA P02545 4/20 0.79
POLB P06746 3/20 0.79
HPGD P15428 1/20 0.79
L3MBTL1 Q9Y468 1/20 0.79
KMT2A Q03164 4/20 0.61
MEN1 O00255 3/20 0.61
APAF1 O14727 1/20 0.61
GRK2 P25098 1/20 0.61
S100A4 P26447 1/20 0.61
CASP6 P55212 1/20 0.61
CTDSP1 Q9GZU7 1/20 0.61
SMN1; SMN2 Q16637 3/20 0.54
GHSR Q92847 1/20 0.54
MAPT P10636 4/20 0.53
HTR6 P50406 1/20 0.52
CYP19A1 P11511 1/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8752412 0.88 L3MBTL1 (1.00) ALDH1A1LMNAPOLBHPGDL3MBTL1
SCHEMBL2992284 0.84 ALDH1A1 (0.67) ALDH1A1LMNAPOLBHPGDL3MBTL1
SCHEMBL8014531 0.84 ALDH1A1 (0.73) ALDH1A1LMNAPOLBHPGDL3MBTL1
SCHEMBL2979871 0.83 ALDH1A1 (0.60) ALDH1A1LMNAPOLBHPGDL3MBTL1
SCHEMBL20578208 0.83 LMNA (0.85) ALDH1A1LMNAPOLBHPGDL3MBTL1
SCHEMBL4730290 0.81 LMNA (0.71) ALDH1A1LMNAPOLBKMT2AMEN1
SCHEMBL3248880 0.81 LMNA (0.69) ALDH1A1LMNAPOLBHPGDL3MBTL1
SCHEMBL2983501 0.80 GHSR (0.57) ALDH1A1LMNAPOLBHPGDL3MBTL1
SCHEMBL27182666 0.80 ALDH1A1 (0.67) ALDH1A1LMNAPOLBHPGDL3MBTL1
SCHEMBL2239360 0.79 HPGD (0.74) ALDH1A1LMNAPOLBHPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS BLANEY EMMA LOUISE 2010-07-15 US disclosed
EP-2007716-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2008-12-31 EP disclosed
WO-2007118852-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179168-A1 ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS GHSR, GHRHR, GIPR ALDH1A1 2521/4885LMNA 4700/4885POLB 4727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.